0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Biologics Drug Discovery Market Research Report 2023
Published Date: February 2023
|
Report Code: QYRE-Auto-0D6239
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global and United States Biologics Drug Discovery Market Report Forecast 2022 2028
BUY CHAPTERS

Global Biologics Drug Discovery Market Research Report 2023

Code: QYRE-Auto-0D6239
Report
February 2023
Pages:101
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Global Biologics Drug Discovery Market

The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization.
The global Biologics Drug Discovery market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Biologics Drug Discovery is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Biologics Drug Discovery is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Biologics Drug Discovery in Hospitals is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Biologics Drug Discovery include GenScript, Roche, Pfizer, Novartis, Sanofi, Merck, GlaxoSmithKline, AstraZeneca and AbbVie, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Biologics Drug Discovery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologics Drug Discovery.
The Biologics Drug Discovery market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Biologics Drug Discovery market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biologics Drug Discovery companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

Key Segmentations

By Company

  • GenScript
  • Roche
  • Pfizer
  • Novartis
  • Sanofi
  • Merck
  • GlaxoSmithKline
  • AstraZeneca
  • AbbVie
  • Amgen
  • Bristol-Myers Squibb
  • Novo Nordisk
  • Allergan
  • Astellas Pharma
  • Teva Pharmaceutical Industries

Segment by Type

  • Biologicals
  • Monoclonal Antibodies
  • Recombinant Proteins
  • Other Biologics

Segment by Application

  • Hospitals
  • Clinics
  • Research Labs
  • Diagnostic Centers
  • Others

By Region

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Nordic Countries
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Biologics Drug Discovery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

Scope of Global Biologics Drug Discovery Market Report

Report MetricDetails
Report NameGlobal Biologics Drug Discovery Market
Base Year2022
Forecasted years2023-2029
Forecast unitsUSD
Report coverageRevenue and volume forecast, company share, competitive landscape, growth factors and trends
Geographic regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biologics Drug Discovery Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Biologicals
1.2.3 Monoclonal Antibodies
1.2.4 Recombinant Proteins
1.2.5 Other Biologics
1.3 Market by Application
1.3.1 Global Biologics Drug Discovery Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Labs
1.3.5 Diagnostic Centers
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biologics Drug Discovery Market Perspective (2018-2029)
2.2 Biologics Drug Discovery Growth Trends by Region
2.2.1 Global Biologics Drug Discovery Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Biologics Drug Discovery Historic Market Size by Region (2018-2023)
2.2.3 Biologics Drug Discovery Forecasted Market Size by Region (2024-2029)
2.3 Biologics Drug Discovery Market Dynamics
2.3.1 Biologics Drug Discovery Industry Trends
2.3.2 Biologics Drug Discovery Market Drivers
2.3.3 Biologics Drug Discovery Market Challenges
2.3.4 Biologics Drug Discovery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biologics Drug Discovery Players by Revenue
3.1.1 Global Top Biologics Drug Discovery Players by Revenue (2018-2023)
3.1.2 Global Biologics Drug Discovery Revenue Market Share by Players (2018-2023)
3.2 Global Biologics Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biologics Drug Discovery Revenue
3.4 Global Biologics Drug Discovery Market Concentration Ratio
3.4.1 Global Biologics Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biologics Drug Discovery Revenue in 2022
3.5 Biologics Drug Discovery Key Players Head office and Area Served
3.6 Key Players Biologics Drug Discovery Product Solution and Service
3.7 Date of Enter into Biologics Drug Discovery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biologics Drug Discovery Breakdown Data by Type
4.1 Global Biologics Drug Discovery Historic Market Size by Type (2018-2023)
4.2 Global Biologics Drug Discovery Forecasted Market Size by Type (2024-2029)
5 Biologics Drug Discovery Breakdown Data by Application
5.1 Global Biologics Drug Discovery Historic Market Size by Application (2018-2023)
5.2 Global Biologics Drug Discovery Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Biologics Drug Discovery Market Size (2018-2029)
6.2 North America Biologics Drug Discovery Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Biologics Drug Discovery Market Size by Country (2018-2023)
6.4 North America Biologics Drug Discovery Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biologics Drug Discovery Market Size (2018-2029)
7.2 Europe Biologics Drug Discovery Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Biologics Drug Discovery Market Size by Country (2018-2023)
7.4 Europe Biologics Drug Discovery Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biologics Drug Discovery Market Size (2018-2029)
8.2 Asia-Pacific Biologics Drug Discovery Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Biologics Drug Discovery Market Size by Region (2018-2023)
8.4 Asia-Pacific Biologics Drug Discovery Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biologics Drug Discovery Market Size (2018-2029)
9.2 Latin America Biologics Drug Discovery Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Biologics Drug Discovery Market Size by Country (2018-2023)
9.4 Latin America Biologics Drug Discovery Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biologics Drug Discovery Market Size (2018-2029)
10.2 Middle East & Africa Biologics Drug Discovery Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Biologics Drug Discovery Market Size by Country (2018-2023)
10.4 Middle East & Africa Biologics Drug Discovery Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GenScript
11.1.1 GenScript Company Detail
11.1.2 GenScript Business Overview
11.1.3 GenScript Biologics Drug Discovery Introduction
11.1.4 GenScript Revenue in Biologics Drug Discovery Business (2018-2023)
11.1.5 GenScript Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Biologics Drug Discovery Introduction
11.2.4 Roche Revenue in Biologics Drug Discovery Business (2018-2023)
11.2.5 Roche Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Biologics Drug Discovery Introduction
11.3.4 Pfizer Revenue in Biologics Drug Discovery Business (2018-2023)
11.3.5 Pfizer Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Biologics Drug Discovery Introduction
11.4.4 Novartis Revenue in Biologics Drug Discovery Business (2018-2023)
11.4.5 Novartis Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Detail
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Biologics Drug Discovery Introduction
11.5.4 Sanofi Revenue in Biologics Drug Discovery Business (2018-2023)
11.5.5 Sanofi Recent Development
11.6 Merck
11.6.1 Merck Company Detail
11.6.2 Merck Business Overview
11.6.3 Merck Biologics Drug Discovery Introduction
11.6.4 Merck Revenue in Biologics Drug Discovery Business (2018-2023)
11.6.5 Merck Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Detail
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Biologics Drug Discovery Introduction
11.7.4 GlaxoSmithKline Revenue in Biologics Drug Discovery Business (2018-2023)
11.7.5 GlaxoSmithKline Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Detail
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Biologics Drug Discovery Introduction
11.8.4 AstraZeneca Revenue in Biologics Drug Discovery Business (2018-2023)
11.8.5 AstraZeneca Recent Development
11.9 AbbVie
11.9.1 AbbVie Company Detail
11.9.2 AbbVie Business Overview
11.9.3 AbbVie Biologics Drug Discovery Introduction
11.9.4 AbbVie Revenue in Biologics Drug Discovery Business (2018-2023)
11.9.5 AbbVie Recent Development
11.10 Amgen
11.10.1 Amgen Company Detail
11.10.2 Amgen Business Overview
11.10.3 Amgen Biologics Drug Discovery Introduction
11.10.4 Amgen Revenue in Biologics Drug Discovery Business (2018-2023)
11.10.5 Amgen Recent Development
11.11 Bristol-Myers Squibb
11.11.1 Bristol-Myers Squibb Company Detail
11.11.2 Bristol-Myers Squibb Business Overview
11.11.3 Bristol-Myers Squibb Biologics Drug Discovery Introduction
11.11.4 Bristol-Myers Squibb Revenue in Biologics Drug Discovery Business (2018-2023)
11.11.5 Bristol-Myers Squibb Recent Development
11.12 Novo Nordisk
11.12.1 Novo Nordisk Company Detail
11.12.2 Novo Nordisk Business Overview
11.12.3 Novo Nordisk Biologics Drug Discovery Introduction
11.12.4 Novo Nordisk Revenue in Biologics Drug Discovery Business (2018-2023)
11.12.5 Novo Nordisk Recent Development
11.13 Allergan
11.13.1 Allergan Company Detail
11.13.2 Allergan Business Overview
11.13.3 Allergan Biologics Drug Discovery Introduction
11.13.4 Allergan Revenue in Biologics Drug Discovery Business (2018-2023)
11.13.5 Allergan Recent Development
11.14 Astellas Pharma
11.14.1 Astellas Pharma Company Detail
11.14.2 Astellas Pharma Business Overview
11.14.3 Astellas Pharma Biologics Drug Discovery Introduction
11.14.4 Astellas Pharma Revenue in Biologics Drug Discovery Business (2018-2023)
11.14.5 Astellas Pharma Recent Development
11.15 Teva Pharmaceutical Industries
11.15.1 Teva Pharmaceutical Industries Company Detail
11.15.2 Teva Pharmaceutical Industries Business Overview
11.15.3 Teva Pharmaceutical Industries Biologics Drug Discovery Introduction
11.15.4 Teva Pharmaceutical Industries Revenue in Biologics Drug Discovery Business (2018-2023)
11.15.5 Teva Pharmaceutical Industries Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Biologics Drug Discovery Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Biologicals
    Table 3. Key Players of Monoclonal Antibodies
    Table 4. Key Players of Recombinant Proteins
    Table 5. Key Players of Other Biologics
    Table 6. Global Biologics Drug Discovery Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 7. Global Biologics Drug Discovery Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 8. Global Biologics Drug Discovery Market Size by Region (2018-2023) & (US$ Million)
    Table 9. Global Biologics Drug Discovery Market Share by Region (2018-2023)
    Table 10. Global Biologics Drug Discovery Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 11. Global Biologics Drug Discovery Market Share by Region (2024-2029)
    Table 12. Biologics Drug Discovery Market Trends
    Table 13. Biologics Drug Discovery Market Drivers
    Table 14. Biologics Drug Discovery Market Challenges
    Table 15. Biologics Drug Discovery Market Restraints
    Table 16. Global Biologics Drug Discovery Revenue by Players (2018-2023) & (US$ Million)
    Table 17. Global Biologics Drug Discovery Market Share by Players (2018-2023)
    Table 18. Global Top Biologics Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics Drug Discovery as of 2022)
    Table 19. Ranking of Global Top Biologics Drug Discovery Companies by Revenue (US$ Million) in 2022
    Table 20. Global 5 Largest Players Market Share by Biologics Drug Discovery Revenue (CR5 and HHI) & (2018-2023)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Biologics Drug Discovery Product Solution and Service
    Table 23. Date of Enter into Biologics Drug Discovery Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Biologics Drug Discovery Market Size by Type (2018-2023) & (US$ Million)
    Table 26. Global Biologics Drug Discovery Revenue Market Share by Type (2018-2023)
    Table 27. Global Biologics Drug Discovery Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 28. Global Biologics Drug Discovery Revenue Market Share by Type (2024-2029)
    Table 29. Global Biologics Drug Discovery Market Size by Application (2018-2023) & (US$ Million)
    Table 30. Global Biologics Drug Discovery Revenue Market Share by Application (2018-2023)
    Table 31. Global Biologics Drug Discovery Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 32. Global Biologics Drug Discovery Revenue Market Share by Application (2024-2029)
    Table 33. North America Biologics Drug Discovery Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 34. North America Biologics Drug Discovery Market Size by Country (2018-2023) & (US$ Million)
    Table 35. North America Biologics Drug Discovery Market Size by Country (2024-2029) & (US$ Million)
    Table 36. Europe Biologics Drug Discovery Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 37. Europe Biologics Drug Discovery Market Size by Country (2018-2023) & (US$ Million)
    Table 38. Europe Biologics Drug Discovery Market Size by Country (2024-2029) & (US$ Million)
    Table 39. Asia-Pacific Biologics Drug Discovery Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 40. Asia-Pacific Biologics Drug Discovery Market Size by Region (2018-2023) & (US$ Million)
    Table 41. Asia-Pacific Biologics Drug Discovery Market Size by Region (2024-2029) & (US$ Million)
    Table 42. Latin America Biologics Drug Discovery Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 43. Latin America Biologics Drug Discovery Market Size by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Biologics Drug Discovery Market Size by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Biologics Drug Discovery Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 46. Middle East & Africa Biologics Drug Discovery Market Size by Country (2018-2023) & (US$ Million)
    Table 47. Middle East & Africa Biologics Drug Discovery Market Size by Country (2024-2029) & (US$ Million)
    Table 48. GenScript Company Detail
    Table 49. GenScript Business Overview
    Table 50. GenScript Biologics Drug Discovery Product
    Table 51. GenScript Revenue in Biologics Drug Discovery Business (2018-2023) & (US$ Million)
    Table 52. GenScript Recent Development
    Table 53. Roche Company Detail
    Table 54. Roche Business Overview
    Table 55. Roche Biologics Drug Discovery Product
    Table 56. Roche Revenue in Biologics Drug Discovery Business (2018-2023) & (US$ Million)
    Table 57. Roche Recent Development
    Table 58. Pfizer Company Detail
    Table 59. Pfizer Business Overview
    Table 60. Pfizer Biologics Drug Discovery Product
    Table 61. Pfizer Revenue in Biologics Drug Discovery Business (2018-2023) & (US$ Million)
    Table 62. Pfizer Recent Development
    Table 63. Novartis Company Detail
    Table 64. Novartis Business Overview
    Table 65. Novartis Biologics Drug Discovery Product
    Table 66. Novartis Revenue in Biologics Drug Discovery Business (2018-2023) & (US$ Million)
    Table 67. Novartis Recent Development
    Table 68. Sanofi Company Detail
    Table 69. Sanofi Business Overview
    Table 70. Sanofi Biologics Drug Discovery Product
    Table 71. Sanofi Revenue in Biologics Drug Discovery Business (2018-2023) & (US$ Million)
    Table 72. Sanofi Recent Development
    Table 73. Merck Company Detail
    Table 74. Merck Business Overview
    Table 75. Merck Biologics Drug Discovery Product
    Table 76. Merck Revenue in Biologics Drug Discovery Business (2018-2023) & (US$ Million)
    Table 77. Merck Recent Development
    Table 78. GlaxoSmithKline Company Detail
    Table 79. GlaxoSmithKline Business Overview
    Table 80. GlaxoSmithKline Biologics Drug Discovery Product
    Table 81. GlaxoSmithKline Revenue in Biologics Drug Discovery Business (2018-2023) & (US$ Million)
    Table 82. GlaxoSmithKline Recent Development
    Table 83. AstraZeneca Company Detail
    Table 84. AstraZeneca Business Overview
    Table 85. AstraZeneca Biologics Drug Discovery Product
    Table 86. AstraZeneca Revenue in Biologics Drug Discovery Business (2018-2023) & (US$ Million)
    Table 87. AstraZeneca Recent Development
    Table 88. AbbVie Company Detail
    Table 89. AbbVie Business Overview
    Table 90. AbbVie Biologics Drug Discovery Product
    Table 91. AbbVie Revenue in Biologics Drug Discovery Business (2018-2023) & (US$ Million)
    Table 92. AbbVie Recent Development
    Table 93. Amgen Company Detail
    Table 94. Amgen Business Overview
    Table 95. Amgen Biologics Drug Discovery Product
    Table 96. Amgen Revenue in Biologics Drug Discovery Business (2018-2023) & (US$ Million)
    Table 97. Amgen Recent Development
    Table 98. Bristol-Myers Squibb Company Detail
    Table 99. Bristol-Myers Squibb Business Overview
    Table 100. Bristol-Myers Squibb Biologics Drug Discovery Product
    Table 101. Bristol-Myers Squibb Revenue in Biologics Drug Discovery Business (2018-2023) & (US$ Million)
    Table 102. Bristol-Myers Squibb Recent Development
    Table 103. Novo Nordisk Company Detail
    Table 104. Novo Nordisk Business Overview
    Table 105. Novo Nordisk Biologics Drug Discovery Product
    Table 106. Novo Nordisk Revenue in Biologics Drug Discovery Business (2018-2023) & (US$ Million)
    Table 107. Novo Nordisk Recent Development
    Table 108. Allergan Company Detail
    Table 109. Allergan Business Overview
    Table 110. Allergan Biologics Drug Discovery Product
    Table 111. Allergan Revenue in Biologics Drug Discovery Business (2018-2023) & (US$ Million)
    Table 112. Allergan Recent Development
    Table 113. Astellas Pharma Company Detail
    Table 114. Astellas Pharma Business Overview
    Table 115. Astellas Pharma Biologics Drug Discovery Product
    Table 116. Astellas Pharma Revenue in Biologics Drug Discovery Business (2018-2023) & (US$ Million)
    Table 117. Astellas Pharma Recent Development
    Table 118. Teva Pharmaceutical Industries Company Detail
    Table 119. Teva Pharmaceutical Industries Business Overview
    Table 120. Teva Pharmaceutical Industries Biologics Drug Discovery Product
    Table 121. Teva Pharmaceutical Industries Revenue in Biologics Drug Discovery Business (2018-2023) & (US$ Million)
    Table 122. Teva Pharmaceutical Industries Recent Development
    Table 123. Research Programs/Design for This Report
    Table 124. Key Data Information from Secondary Sources
    Table 125. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Biologics Drug Discovery Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Biologics Drug Discovery Market Share by Type: 2022 VS 2029
    Figure 3. Biologicals Features
    Figure 4. Monoclonal Antibodies Features
    Figure 5. Recombinant Proteins Features
    Figure 6. Other Biologics Features
    Figure 7. Global Biologics Drug Discovery Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 8. Global Biologics Drug Discovery Market Share by Application: 2022 VS 2029
    Figure 9. Hospitals Case Studies
    Figure 10. Clinics Case Studies
    Figure 11. Research Labs Case Studies
    Figure 12. Diagnostic Centers Case Studies
    Figure 13. Others Case Studies
    Figure 14. Biologics Drug Discovery Report Years Considered
    Figure 15. Global Biologics Drug Discovery Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 16. Global Biologics Drug Discovery Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 17. Global Biologics Drug Discovery Market Share by Region: 2022 VS 2029
    Figure 18. Global Biologics Drug Discovery Market Share by Players in 2022
    Figure 19. Global Top Biologics Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics Drug Discovery as of 2022)
    Figure 20. The Top 10 and 5 Players Market Share by Biologics Drug Discovery Revenue in 2022
    Figure 21. North America Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. North America Biologics Drug Discovery Market Share by Country (2018-2029)
    Figure 23. United States Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. Canada Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. Europe Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. Europe Biologics Drug Discovery Market Share by Country (2018-2029)
    Figure 27. Germany Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. France Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. U.K. Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Italy Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Russia Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Nordic Countries Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Asia-Pacific Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. Asia-Pacific Biologics Drug Discovery Market Share by Region (2018-2029)
    Figure 35. China Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. Japan Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. South Korea Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Southeast Asia Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. India Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Australia Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Latin America Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Latin America Biologics Drug Discovery Market Share by Country (2018-2029)
    Figure 43. Mexico Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Brazil Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Middle East & Africa Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. Middle East & Africa Biologics Drug Discovery Market Share by Country (2018-2029)
    Figure 47. Turkey Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 48. Saudi Arabia Biologics Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 49. GenScript Revenue Growth Rate in Biologics Drug Discovery Business (2018-2023)
    Figure 50. Roche Revenue Growth Rate in Biologics Drug Discovery Business (2018-2023)
    Figure 51. Pfizer Revenue Growth Rate in Biologics Drug Discovery Business (2018-2023)
    Figure 52. Novartis Revenue Growth Rate in Biologics Drug Discovery Business (2018-2023)
    Figure 53. Sanofi Revenue Growth Rate in Biologics Drug Discovery Business (2018-2023)
    Figure 54. Merck Revenue Growth Rate in Biologics Drug Discovery Business (2018-2023)
    Figure 55. GlaxoSmithKline Revenue Growth Rate in Biologics Drug Discovery Business (2018-2023)
    Figure 56. AstraZeneca Revenue Growth Rate in Biologics Drug Discovery Business (2018-2023)
    Figure 57. AbbVie Revenue Growth Rate in Biologics Drug Discovery Business (2018-2023)
    Figure 58. Amgen Revenue Growth Rate in Biologics Drug Discovery Business (2018-2023)
    Figure 59. Bristol-Myers Squibb Revenue Growth Rate in Biologics Drug Discovery Business (2018-2023)
    Figure 60. Novo Nordisk Revenue Growth Rate in Biologics Drug Discovery Business (2018-2023)
    Figure 61. Allergan Revenue Growth Rate in Biologics Drug Discovery Business (2018-2023)
    Figure 62. Astellas Pharma Revenue Growth Rate in Biologics Drug Discovery Business (2018-2023)
    Figure 63. Teva Pharmaceutical Industries Revenue Growth Rate in Biologics Drug Discovery Business (2018-2023)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Microcarrier Bioreactor Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-4O8609
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Immunohistochemistry Reagent Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-25I8231
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global RNA Analysis & Transcriptomic Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-2M4266
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global PCR Tubes And PCR Plates Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-38E8328
Wed Apr 17 00:00:00 UTC 2024

Add to Cart